All-cause mortality and pharmacological treatment intensity following a high risk screening program for diabetes. A 6.6 year follow-up of the ADDITION study, Denmark

Primary Care Diabetes

Volumn 6, Issue 3, 2012, Pages 193-200

  Lauritzen, Torsten ^a   Sandbaek, Annelli ^a   Carlsen, Anders Helles ^a   Borch Johnsen, Knut ^a,b  

^a AARHUS UNIVERSITY   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Intensive treatment of type 2 diabetes; Screen detected type 2 diabetes; Screening for diabetes; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; DENMARK; DIABETES MELLITUS; DYSGLYCEMIA; FEMALE; FOLLOW UP; GLUCOSE METABOLISM; HIGH RISK POPULATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MORTALITY; PREDICTIVE VALUE; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL;

ADULT; ANTIHYPERTENSIVE AGENTS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CHI-SQUARE DISTRIBUTION; COMORBIDITY; DENMARK; DIABETES MELLITUS; DYSLIPIDEMIAS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; KAPLAN-MEIER ESTIMATE; MALE; MASS SCREENING; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84865782353     PISSN: 17519918     EISSN: 18780210     Source Type: Journal    
DOI: 10.1016/j.pcd.2012.04.005     Document Type: Article

References (24)

1. IDF, The Diabetes Atlas, fourth ed., Brussels, 2009.
2. P. Gaede, H. Lund-Andersen, H.H. Parving, and O. Pedersen Effect of a multifactorial intervention on mortality in type 2 diabetes New England Journal of Medicine 358 6 2008 580 591 (Pubitemid 351214285)
3. T. Lauritzen, S. Griffin, J.K. Borch, and N.J. Wareham The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening International Journal of Obesity and Related Metabolic Disorders 24 Suppl. 3 2000 6 11
4. S.J. Griffin, K. Borch-Johnsen, M.J. Davies, K. Khunti, G.E. Rutten, and S. Sanders Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial Lancet 378 9786 2011 156 167
5. S. Nakanishi, M. Yamada, N. Hattori, and G. Suzuki Relationship between HbA(1)c and mortality in a Japanese population Diabetologia 48 2 2005 230 234 (Pubitemid 40543294)
6. K.T. Khaw, N. Wareham, R. Luben, S. Bingham, S. Oakes, and A. Welch Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European prospective investigation of cancer and nutrition (EPIC-Norfolk) British Medical Journal 322 7277 2001 15 18 (Pubitemid 32066250)
7. K.T. Khaw, N. Wareham, S. Bingham, R. Luben, A. Welch, and N. Day Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk Annals of Internal Medicine 141 6 2004 413 420
8. V.F. de, J.M. Dekker, C.D. Stehouwer, G. Nijpels, L.M. Bouter, and R.J. Heine Similar 9-year mortality risks and reproducibility for the World Health Organization and American Diabetes Association glucose tolerance categories: the Hoorn Study Diabetes Care 23 1 2000 40 44 (Pubitemid 30022892)
9. V.F. de, J.M. Dekker, H.G. Ruhe, C.D. Stehouwer, G. Nijpels, and L.M. Bouter Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study Diabetologia 42 8 1999 926 931 (Pubitemid 29369599)
10. N. Brewer, C.S. Wright, N. Travier, C.W. Cunningham, J. Hornell, and N. Pearce A New Zealand linkage study examining the associations between A1C concentration and mortality Diabetes Care 31 6 2008 1144 1149
11. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe The Lancet 354 9179 1999 617 621
12. C. Glumer, B. Carstensen, A. Sandbaek, T. Lauritzen, T. Jorgensen, and K. Borch-Johnsen A Danish diabetes risk score for targeted screening: the Inter99 study Diabetes Care 27 3 2004 727 733 (Pubitemid 38280541)
13. R.M. Conroy, K. Pyorala, A.P. Fitzgerald, S. Sans, A. Menotti, and B.G. De Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project European Heart Journal 24 11 2003 987 1003 (Pubitemid 36712275)
14. K.G. Alberti, and P.Z. Zimmet Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation Diabetic Medicine 15 7 1998 539 553 (see comments) (Pubitemid 28319935)
15. Prevention of Ischemic Heart Disease in General Practice. Guideline from the Danish College of General Practitioners, 1998. www.dsam.dk/flx/dsams- kliniske-vejledninger/download-vejledninger/.
16. Type 2 Diabetes in General Practice - Diagnosis and Treatment. Guideline from the Danish College of General Practitioners, 1999. www.dsam.dk/flx/dsams- kliniske-vejledninger/download-vejledninger/.
17. A. Sandbaek, T. Lauritzen, K. Borch-Johnsen, K. Mai, and J.S. Christiansen The comparison of venous plasma glucose and whole blood capillary glucose in diagnoses of Type 2 diabetes: a population-based screening study Diabetic Medicine 22 9 2005 1173 1177 (Pubitemid 41224176)
18. WHO Collaborating Centre for Drug Statistics Methodology, Guidelines for ACT Classification and DDD Assignment 2010, Oslo, 2010. http://www.whocc.no/atc- ddd-index/.
19. R.R. Wing Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial Archives of Internal Medicine 170 17 2010 1566 1575
20. T. Lauritzen, M.S. Jensen, J.L. Thomsen, B. Christensen, and M. Engberg Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5-year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP) Scandinavian Journal of Public Health 36 6 2008 650 661
21. L. Graversen, B. Christensen, K. Borch-Johnsen, T. Lauritzen, and A. Sandbaek General practitioners' adherence to guidelines on management of dyslipidaemia: ADDITION-Denmark Scandinavian Journal of Primary Health Care 28 1 2010 47 54
22. T. Lauritzen, A. Sandbaek, M.V. Skriver, and K. Borch-Johnsen HbA(1c) and cardiovascular risk score identify people who may benefit from preventive interventions: a 7 year follow-up of a high-risk screening programme for diabetes in primary care (ADDITION), Denmark Diabetologia 54 6 2011 1318 1326
23. R. Kahn, P. Alperin, D. Eddy, K. Borch-Johnsen, J. Buse, and J. Feigelman Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis The Lancet 375 9723 2010 1365 1374
24. S.R. Rasmussen, J.L. Thomsen, J. Kilsmark, A. Hvenegaard, M. Engberg, and T. Lauritzen Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs Scandinavian Journal of Public Health 35 4 2007 365 372 (Pubitemid 47386785)